Stock screener

NBIX

Conviction 22HealthcareScan · Thu, Sep 24, 2026

Neurocrine Biosciences Inc (NBIX) closed at $139.02 (-0.34%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 26, RS Rating 27, -25.1% from its 52-week high, -1.1% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).

NBIX$139.02-0.34%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
2
2
2
Vol MA14 1.23M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
NEUROCRINE BIOSCIENCES INCBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.neurocrine.com ↗
Price139.02
Change-0.34%
Gap-0.37%
Rel volume0.96×
Avg volume1.16M
Avg $ vol174.03M
SMA 20151.76
SMA 50159.62
SMA 200147.70
Price vs 50-12.91%
Price vs 200-5.87%
MA stackmixed
50/200 cross—
Supertrenddown · 150.72
RSI (14)26
MACD hist-1.32
MACD crossbear · 6d
Stoch %K / %D9 / 4
ADX (14)27
+DI / −DI12 / 38
RSI divergence—
MACD divergence—
ATR %2.99%
ADR %2.59%
52w high185.50
52w low123.10
From 52w high-25.06%
Above 52w low+12.93%
New 52w highNo
SqueezeOff
Bollinger width16.10%
%B-0.02
Donchian pos8.99%
Donchian high160.43
Donchian low136.91
AVWAP (52w high)157.00
vs AVWAP high-11.45%
AVWAP (52w low)150.06
vs AVWAP low-7.36%
OBV trendDown
Chaikin MF (20)-0.25
Today vs 20d0.96×
Avg vol (14d)1.23M
Avg vol (20d)1.16M
Avg $ vol (20d)174.03M
Market cap14.13B
RS Rating27 / 99
RS 3m (vs SPY)-19.82%
RS 6m (vs SPY)-10.80%
RS line new highNo
Trend template3/8
Technical rank31.8
1 week-8.44%
1 month-9.36%
3 months-15.32%
6 months+6.02%
1 year-5.04%
YTD-1.12%
P/E29.53
P/B3.83
P/S4.94
P/FCF18.87
EPS4.67
Div yield—
ROE12.96%
ROA8.93%
Debt/Eq—
Current1.87
EV/EBITDA22.14
Gross margin—
Net margin16.73%
Rev growth21.45%
EPS growth40.23%
Price target209.36
Target upside50.60%
Analyst ratingBuy
Institutional110.56%
Ent. value13.8B
Revenue959M
Net income144.4M
Gross profit—
Free cash flow748.7M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out100.55M
Employees2K
ListedThu, May 23, 1996
Free float94.62M
Float %94.1%
Short interest5.06M
Days to cover4.7d
Short volume70.3%
Squeeze score54 / 100
Next earnings—
EPS forecast—
Last EPS vs est$2.36 vs $1.88
Last surprise+25.5% beat
Setup gradeD
Conviction22 / 100
Pattern quality—
Tech rank31.8 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance162.94
Support150.27
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in NBIX · 2 recent

All disclosures →
MemberSideAmount
Lisa McClain
Lisa McClain
house · R · MI · traded 2025-06-17
Sell$1K–$15K
Lisa McClain
Lisa McClain
house · R · MI · traded 2025-06-11
Buy$1K–$15K

Insider activity

SEC Form 4 transactions in NBIX · open-market 2 sells

InsiderSideShares
ABERNETHY MATT
Chief Financial Officer · Common Stock · 2026-09-14
Sell2.31K
Boyer David W.
Chief Corp. Affairs Officer · Common Stock · 2026-09-14
Sell826
BENEVICH ERIC
Chief Commercial Officer · Common Stock · 2026-09-11
Grant6.28K
BENEVICH ERIC
Chief Commercial Officer · Common Stock · 2026-09-11
Tax3.39K
Boyer David W.
Chief Corp. Affairs Officer · Common Stock · 2026-09-11
Grant3.59K
Boyer David W.
Chief Corp. Affairs Officer · Common Stock · 2026-09-11
Tax1.94K
Cooke Julie
Chief Human Resources Officer · Common Stock · 2026-09-11
Grant3.59K
Cooke Julie
Chief Human Resources Officer · Common Stock · 2026-09-11
Tax1.94K
Delaet Ingrid
Chief Regulatory Officer · Common Stock · 2026-09-11
Grant4.48K
Delaet Ingrid
Chief Regulatory Officer · Common Stock · 2026-09-11
Tax2.42K

SEC filings

EDGAR filings in NBIX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.